Tagged: Trump Administration

Has Uncle Sam Terminated Your Federal Grant? You Have Rights (and Maybe a Financial Claim)

The Dorsey Health Law blog team keeps readers up-to-date on relevant topics in the health care industry. In order to do so, the members of the blog team communicate regularly with other practice groups within the firm for applicable updates from client publications. For this post, we would like to thank Dorsey’s Alex Hontos, Chris...

Federal Grant and Loan “Temporary Pause” to Have a Significant Impact on the Health Care Industry

UPDATE – January 29, 2025: The Trump Administration rescinded the OMB memorandum ordering the federal grant and loan pause on January 29, 2025.   UPDATE – January 28, 2025: The federal grant and loan pause described in this blog post has been temporarily enjoined by a U.S. District Court until February 3, 2025 for funds...

ICE in your Healthcare Facility? No Need to Freeze

For over a decade, agents with U.S. Immigration and Customs Enforcement (“ICE”) were instructed pursuant to official policies to refrain from conducting law enforcement actions in or near various “sensitive locations” or “protected areas,” such as healthcare facilities, schools, and churches. Exceptions existed in the policies for exigent circumstances, such as when the enforcement action...

Federal Assistance in Jeopardy? What to Know about OMB Guidance About Hundreds of Billions in Federal Research and Loans to Research Institutions, Universities, and Private Organizations

The Dorsey Health Law blog team keeps readers up-to-date on relevant topics in the health care industry. In order to do so, the members of the blog team communicate regularly with other practice groups within the firm for applicable updates from client publications. For this post, we would like to thank Dorsey’s Alex Hontos, Christopher...

How Trump Policy Shifts Will Affect Employers’ Relationship With Their Employees

Upcoming Webinar: Just a few days into the Trump administration, employers have seen drastic shifts in enforcement relating to DEI programs, federal contracting requirements, and transgender rights in the workplace, and further changes are expected, as well as legal challenges. Employers will be left to navigate these developments legally while simultaneously responding to employee questions...

Proposed Drug Rebate and PBM Service Fee Regulations Abandoned by Administration

As reported here in February, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) released two new significant proposed regulations that would have had a transformative effect on the drug discount and rebate arrangements that are commonplace between pharmaceutical manufacturers and Medicare Part D Plans and Medicaid Managed Care Organizations (and...

Court Invalidates Final Rule Requiring Advertisements to List Drug Prices Finding that CMS Exceeded Its Statutory Authority

In a much anticipated decision, a federal judge ruled this week that the Trump Administration’s rule requiring drug manufacturers to list drug prices in television advertisements exceeds the agency’s authority. Back in May 2018, the Trump administration spoke on drug pricing and published its “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”. One of...

CMS Announces Rural Health Strategy

Last week the Centers for Medicare & Medicaid Services (“CMS”) released its first Rural Health Strategy. The strategy is intended to improve the agency’s service to individuals living in rural areas. CMS’ Rural Health Council, created during the Obama Administration, developed the strategy by examining current rural-focused programs at CMS, reviewing the methods used by...